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SUMMARY
The aim of this study was to provide a comprehensive genetic/phenotypic characterization of subjects suffering infertility owing to
sperm macrocephaly (n = 3) or globozoospermia (n = 9) and to investigate whether the patients’ genetic status was correlated with
the alteration of various sperm parameters. AURKC was sequenced in case of sperm macrocephaly while the DPY19L2 status has
been analyzed by multiple approaches including a novel qPCR–based copy number assay in case of globozoospermia. Globozoosper-
mic patients were also analyzed for SPACA1, a novel candidate gene herein tested for the first time in humans. The effect of the
patients’ genetic status was interrogated by implementing the molecular screening with the characterization of several sperm param-
eters: (i) routine sperm analysis, integrated with transmission electron microscopy; (ii) sperm fluorescent in situ hybridization (FISH)
analysis; (iii) sperm DNA fragmentation (DF) analysis. Moreover, for the first time, we performed microsatellite instability analysis as
a marker of genome instability in men with sperm macrocephaly and globozoospermia. Finally, artificial reproductive technology
(ART) history has been reported for those patients who underwent the treatment. Macrocephalic patients had an AURKC mutation
and >89% tetraploid, highly fragmented spermatozoa. DPY19L2 was mutated in all patients with >80% globozoospermia: the two
homozygous deleted men and the compound heterozygous showed the severest phenotype (90–100%). The newly developed qPCR
method was fully validated and has the potential of detecting also yet undiscovered deletions. DPY19L2 status is unlikely related to
FISH anomalies and DF, although globozoospermic men showed a higher disomy rate and DF compared with internal reference
values. No patient was mutated for SPACA1. Our data support the general agreement on the negative correlation between macro/
globozoospermia and conventional intracytoplasmic sperm injection outcomes. Microsatellites were stable in all patients analyzed.
The comprehensive picture provided on these severe phenotypes causing infertility is of relevance in the management of patients
undergoing ART.
INTRODUCTION
It is estimated that infertility affects about 7% of men in their
reproductive age (Krausz, 2011). The etiology of male infertility
also includes two monomorphic forms of teratozoospermia,
sperm macrocephaly, and globozoospermia. Sperm macroceph-
aly is described as a rare condition with a <1% prevalence in the
subfertile population (Nistal et al., 1977) and is characterized by
large-headed and multi-flagellated spermatozoa. Globozoosper-
mia (incidence of 0.1%) is characterized by the production of
round-headed acrosomeless spermatozoa that are unable to
fertilize the oocyte, as no acrosome reaction can occur (Sen
et al., 2009).
Literature offers a number of studies dealing with sperm
macrocephaly or globozoospermia in relation to artificial repro-
ductive technology (ART) outcomes (Koscinski et al., 2011; Dam
et al., 2012; Shimizu et al., 2012; Molinari et al., 2013). These
studies demonstrate that such sperm morphological defects are
related to impairment of spontaneous conception and that a
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better option should be intracytoplasmic sperm injection (ICSI),
although the fertilization rate is relatively low or even absent in
pure forms of macro/globozoospermia. Assisted oocyte activa-
tion (AOA) has been proposed as treatment for globozoospermic
patients (Kuentz et al., 2013).
A number of studies focused on the relationship between ter-
atozoospermia and sperm DNA fragmentation (DF), and the
majority reports that teratozoospermic males had a sperm DF
significantly higher than fertile men (Vicari et al., 2002; Egashira
et al., 2009; Brahem et al., 2011; Perrin et al., 2011; Mangiarini
et al., 2013). As for sperm aneuploidies, a different picture is por-
trayed according to whether we refer to sperm macrocephaly or
globozoospermia: regarding the former, a high incidence of
sperm chromosomal abnormalities is observed in patients with
large-headed spermatozoa, typically displaying a >95% of poly-
ploid/aneuploid genetic content (Benzacken et al., 2001; Perrin
et al., 2008; Brahem et al., 2011); concerning the latter, a com-
prehensive review of 16 studies dealing with globozoospermia
(Perrin et al., 2013) reports that, on the contrary, this form of ter-
atozoospermia shows a much lower rate of aneuploidy and on
average does not appear to be responsible for higher rates of
sperm chromosomal anomalies.
Concerning the genetic background, sperm macrocephaly can
be caused by the occurrence in homozygosity of a 1-bp deletion
(c.144delC) in the AURKC gene, which is essential for correct
meiotic chromosomal segregation and cytokinesis (Dieterich
et al., 2007). This mutation results in a truncated protein lacking
the kinase domain, which leads to a blockage of both meiotic
divisions finally causing the presence of tetraploidy and numer-
ous flagella. The c.144delC has been reported to occur exclu-
sively in the North African ancestry, suggesting the possibility of
a founder effect (Dieterich et al., 2009; Ben Khelifa et al., 2011,
2012; El Kerch et al., 2011). Dieterich et al. (2009) reported one
patient with a pure phenotype displaying the c.144delC muta-
tion in compound heterozygosis with a newly found missense
mutation, p.C229Y (c.686G>A). A heterozygous splicing mutation
in exon 5 (c.436-2A>G) was also identified in two affected broth-
ers who also carried the c.144delC mutation (Ben Khelifa et al.,
2011). Later, the same authors (Ben Khelifa et al., 2012), identi-
fied the p.Y248* (c.744C>G; rs55658999) variant in homozygosis
in six men of North African origin and in four Europeans, of
which two were homozygous and two were compound heterozy-
gous for the c.144delC. This nonsense mutation was always asso-
ciated with another variant located in AURKC 30UTR,
c.930+38G>A. In addition, a single case of sperm macrocephaly
has been recently reported without mutations in the AURKC
gene (Molinari et al., 2013).
Regarding globozoospermia, a genetic basis was suggested by
the familial distribution of the syndrome (Kilani et al., 2004),
and different patterns of inheritance (polygenic, X-linked, auto-
somal dominant, autosomal recessive) have been proposed
(Trokoudes et al., 1995; Stone et al., 2000). Presently, the most
prevalent genetic defect observed in human globozoospermia is
a ~200 Kb homozygous deletion of DPY19L2 (12q14.2), firstly
identified by a genome-wide scan analysis using a 10K SNP
array (Koscinski et al., 2011). It has been proved that DPY19L2
deletion leads to the blockage of sperm head elongation and
acrosome formation. This might be explained by the fact that
the absence of the protein leads to the destabilization of both
the nuclear dense lamina and the junction between the
acroplaxome and the nuclear envelope. Consequently, the acro-
some and the manchette fail to be linked to the nucleus leading
to the disruption of vesicular trafficking, failure of sperm
nuclear shaping and eventually to the elimination of the
unbound acrosomal vesicle. Finally, two further genes have
been associated with globozoospermia in humans, SPATA16
and PICK1 (Perrin et al., 2013). The former was firstly proposed
as possibly implicated in globozoospermia by Dam et al.
(2007), who identified a homozygous mutation in the spermato-
genesis-specific gene SPATA16. The localization in the Golgi
apparatus and the shift with Golgi vesicles to the acrosome
observed in round and elongated spermatids suggested a role
for the SPATA16 protein in acrosome formation during sper-
miogenesis (Lu et al., 2006). As for the PICK1 gene, it encodes a
peripheral membrane protein involved in protein trafficking, a
function that has been well characterized in neurons. Apart
from being expressed in the brain, the PICK1 protein shows rel-
atively high levels also in the testes and the pancreas. The first
association with globozoospermia was reported by Xiao et al.
(2009), who showed that Pick1-knockout mice displayed similar
sperm anomalies to those found in human globozoospermia.
Then, in another Chinese study, PICK1 was screened for the
first time in humans and a homozygous missense mutation
(G198A) was reported as the cause of the globozoospermic phe-
notype. Studies on mice models showed that disruption of
other genes, that is, Csnk2a2 (Xu et al., 1999), Hrb (Kang-Decker
et al., 2001), Gopc (Yao et al., 2002) and the most recently
reported Spaca1 (Fujihara et al., 2012), results in a phenotype
resembling that of globozoospermia in humans. Mutational
screening has been performed in humans for CSNK2A2, HRB,
and GOPC (Pirrello et al., 2005; Christensen et al., n.d.), but no
mutations potentially linked to the pathology were found.
Instead, no genetic studies are available on human SPACA1,
making this gene an interesting genetic target of investigation.
SPACA1 (6q15) encodes a membrane protein localized in the
equatorial segment of spermatozoa. Immunohistochemistry of
human testicular cells (Hao et al., 2002) demonstrated that
SPACA1 distribution coincided with acrosome development
and that rat anti-SPACA1 antibodies blocked the binding and
fusion of capacitated human spermatozoa with zona-free ham-
ster eggs.
Present literature offers the description of different aspects of
these two forms of teratozoospermia, but the picture provided
remains partial as available studies focus on specific issues sepa-
rately. The major aim of this study was to provide a genetic
screening of the two known causative genes, AURKC in case of
sperm macrocephaly and DPY19L2 in case of globozoospermia.
In addition, our patients were also tested for SPACA1, a novel
candidate gene herein tested for the first time in humans. To
provide a comprehensive phenotypic description, we imple-
mented the genetic investigation with the characterization of
both previously analyzed and novel sperm parameters. Hence,
our patients were also subjected to routine sperm analysis, inte-
grated with transmission electron microscopy (TEM) to finely
characterize sperm morphology, sperm fluorescent in situ
hybridization (FISH) analysis and sperm DF analysis. Moreover,
for the first time, we performed microsatellite instability (MSI)
analysis as a marker of genome instability in teratozoospermic
men. Studies in the literature reported that in these two types of
monomorphic teratozoospermia the observed pregnancy rate is
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rather low (Viville et al., 2000; Dam et al., 2007; Molinari et al.,
2013); therefore, by performing the MSI analysis we aimed at
understanding whether this phenomenon might be because of a
higher instability of these patients’ genome. Finally, ART history
has been reported for those patients who underwent the treat-
ment. This is the first comprehensive study that cumulatively
collects a relevant load of information on two types of morpho-
logical defects of human spermatozoa with potential benefit for
future medical practice.
MATERIALS ANDMETHODS
Subjects
A total of twelve unrelated patients displaying a >90% terato-
zoospermic phenotype of sperm macrocephaly (n = 3) and
globozoospermia (n = 9) were selected for this study. All patients
consulted for primary infertility to the Fundacio Puigvert, Spain
(n = 4) and to the Division of Sexual Medicine and Andrology
Unit, University Hospital Careggi, Italy (n = 8). Two patients,
one referring to the Spanish clinic and the other referring to the
Italian one, had North African origins, whereas the remaining 10
patients had no known ascendants from North Africa. None of
the patients had karyotype anomalies or Y-chromosome mic-
rodeletions. The brother of one of the Spanish macrocephalic
patients was also recruited. Genetic and sperm analyses were
performed in the frame of the diagnostic work-up. All partici-
pants and family members gave written, informed consent for
the analyses.
Routine sperm analysis
Semen parameters were assessed according to the WHO
guidelines (WHO, 2010; Data S1).
Transmission electron microscopy
TEM analyses were requested as a service at the University
Hospital of Siena and performed as described elsewhere (Bacc-
etti et al., n.d.) (Data S1).
Fluorescent in situ hybridization
For patients attending the Italian clinic, FISH was provided by
the University Hospital of Siena according to the protocol
described by Baccetti et al. (2003). For patients referring to the
Spanish clinic, the analysis was performed at Reprogenetics
(Barcelona, Spain) according to the protocol described by
Sanchez-Castro et al. (2009) (Data S1).
Terminal deoxynucleotidyl transferase dUTP nick end labeling/pro-
pidium iodide assay
Sperm DF was determined by TUNEL/PI assay as described
elsewhere (Muratori et al., 2008); Data S1).
MSI analysis
Seven microsatellite loci located on different chromosomes
were investigated using genomic DNA from both peripheral
blood and sperm samples belonging to the same subject. In this
study, selected loci consisted of two mononucleotide tandem
repeats (BAT-25 and BAT-26), three dinucleotide tandem repeats
(D2S123, D17S250, D5S346), one dinucleotide (TA)n repeat locus
[within the promoter of the estrogen receptor (ESR1)] and one
trinucleotide (CAG)n repeat locus [within exon 1 of the androgen
receptor (AR)] (Table S1). MSI was defined as the presence of
discordant alleles between blood and sperm DNA belonging to
the same subject. Details are provided in the Data S1.
Candidate genes analysis
Sanger sequencing was performed using the BigDye Termina-
tor v3.1 sequencing kit and an ABI PRISM 3130 Genetic Ana-
lyzer (Applied Biosystems, Foster City, CA, USA). As for
macrocephalic patients, the seven AURKC exons and intron/
exon boundaries were analyzed (primers reported in Table S2).
Concerning globozoospermic patients, the DPY19L2 and
SPACA1 genes were analyzed. As for DPY19L2, screening was
performed according to the flow chart represented in Figure S1.
Standard  PCR of exons 10, 14, and 19 served to detect the
complete homozygous deletion. Deletion junction fragment
analysis (DJFA) was performed to detect the heterozygous
DPY19L2 deletion in STS (Sequence-Tagged Sites)-positive
patients and to define the type of breakpoint (Elinati et al.,
2012) in heterozygous and homozygous deletions. Primers used
are reported in Table S3. Mutational screening by direct
sequencing was also performed and pathogenic predictions for
missense variations were realized using Polyphen (http://genet-
ics.bwh.harvard.edu/pph2/), SIFT (http://sift.jcvi.org) and Mu-
tationTaster (www.mutationtaster.org). Intronic variants
predictions were performed using Human Splice Finder
(www.umd.be/HSF/) and BDGP (www.fruitfly.org/) websites.
Multiple sequence alignment of the human DPY19L2 protein
among species was performed with MultAlin (http://multa-
lin.toulouse.inra.fr/multalin/). The effect of the missense vari-
ants on the properties of the involved extramembrane loops of
the DPY19L2 protein was predicted using TMHMM server v.2
(http://www.cbs.dtu.dk/services/TMHMM/). As for SPACA1,
primers were designed to amplify and sequence all seven exons
and intron/exon boundaries (Table S4).
Quantitative-PCR
Exploration on the DPY19L2 locus in the Database of Genomic
Variants (DGV) showed a threefold increase in duplications
compared with deletions, and that several deletions might have
a different breakpoint possibly undetected by standard DJFA.
Therefore, we applied qPCR to identify both novel deletions and
duplications involving the DPY19L2 gene by designing a TaqMan
assay based on the amplification of the 50UTR-Exon1 region
(Data S1 and Table S5).
Statistical analysis
The statistical software SPSS 20.0 (Chicago, IL, USA) was
employed. Comparison of DF mean values was performed with
the parametric independent t-test, according to the fact that
sperm DF was normally distributed among samples. A p-value
<0.05 was considered statistically significant.
RESULTS
Sperm analysis
Routine semen analysis
As for macrocephalic patients, two (11-527 and 12-550) pre-
sented a moderate reduction in total sperm count (17.5 and
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16 million/ejaculate, respectively), whereas CT154 sperm count
was normal (64.3 million/ejaculate). Sperm morphology analysis
showed in all patients 100% combined anomalies including the
typical features of sperm macrocephaly (Fig. 1A). As for globo-
zoospermic patients, total sperm count varied from very low to
normal with variable percentages of round-headed acrosomeless
spermatozoa (50–100%).
TEM analysis
TEM evaluation was performed in three patients with globo-
zoospermia, A1869, CT158, and CT196. The analysis revealed in
all cases the presence of typical sperm head morphology altera-
tions with most of the analyzed nuclei presenting a high level of
chromatin decondensation; sperm flagella appeared disorga-
nized and coiled around the nucleus (Fig. 1B). Patient CT158
also presented rarely elliptic or elongated nuclei and some
perinuclear structures possibly representing a developmental
failure of the acrosome.
Sperm FISH
FISH analysis was performed in all patients affected by macro-
cephaly and in four of nine patients with globozoospermia.
Although the number of chromosomes analyzed was different
in the Spanish and Italian patients (5 and 3, respectively) the
results were very similar. As expected, the most frequent sperm
chromosomal anomaly in patients with sperm macrocephaly
was tetraploidy (mean value  standard deviation: 84.27 
9.66%), but also disomies/diploidies were higher than reference
values (disomies: 4.29  3.40%; diploidies: 7.15  2.55%). Sper-
matozoa of globozoospermic patients mostly presented with a
normal sperm chromosomal content, although average
disomies/diploidies levels were higher than reference values
(disomies: 0.61  0.26%; diploidies: 0.53  0.31%) (Table S6).
Sperm DF analysis
TUNEL/PI assay was performed for two macrocephalic and
eight globozoospermic patients. Macrocephalic patients’ (CT154
and 12-550) sperm DF was 54.29 and 52%, respectively, although
it did not reach statistical significance compared with the inter-
nal reference values calculated on a population of 90 fertile con-
trols, probably because of the small number (n = 2). Among
globozoospermic patients, the proportion of fragmented sper-
matozoa varied from 32.61% (patient CT190) to 64.9% (patient
CT196) with a mean value that was significantly higher com-
pared with the internal reference values (mean value  standard
error: 46.92  4.20% vs. 34.04  1.53%; p = 0.017; Table 1).
Microsatellite instability
MSI analysis was performed for one of three macrocephalic
patients (CT154) and for eight globozoospermic patients. In each
patient, all seven markers analyzed resulted stable between sper-
matozoa and blood DNA samples (Table 1).
Molecular genetics
AURKC screening
The two macrocephalic patients with North African origin
(CT154 and 11-527) carried the c.144delC mutation. The other
patient, as well as his brother, were homozygous for the
p.Tyr248* (c.744C>G) mutation in exon 6 (Table S7); both broth-
ers also carried the c.930 + 38C>G mutation in the 30UTR,
reported to be in linkage with the p.Tyr248* mutation (Ben Khe-
lifa et al., 2012).
DPY19L2 screening
Three patients carried the DPY19L2 deletion: A1869 and
CT190, who were homozygous, and CT158, who was heterozy-
gous. DJFA resulted in the amplification of the expected 1.7 Kb
product in all of them, revealing the presence of breakpoint type
‘a’. The rest of patients showed amplification of all exons, thus
qPCR analysis was performed to check whether they harbored
novel deletions undetectable by DJFA. Q-PCR confirmed the
presence of the heterozygous deletion in CT158 as well as the
homozygous deletion in CT190 and A1869, but no other novel
CNVs were found in the remaining samples. Finally, sequencing
was performed to check for the presence of point mutations in
(A)
(B)
Figure 1 Representative view of sperm morphology. (A) Macrocephalic
patients’ ejaculate presented 100% large-headed and multi-flagellated
spermatozoa (in the picture, CT154’s spermatozoa are showed). (B) Round-
headed and acrosomeless spermatozoa depicted by TEM in globozoosper-
mic patients (in the picture, CT158’s spermatozoa are showed).
206 Andrology, 2015, 3, 203–212 © 2015 American Society of Andrology and European Academy of Andrology
C. Chianese et al. ANDROLOGY
the heterozygous deletion carrier (CT158) and the non-deleted
patients (n = 6).
The heterozygous patient did not show any amplification of
exon 7, suggesting a deletion of this exon. The consequence at
the protein level is the loss of 20 amino acids, predicted by
TMHMM to substantially change the protein conformation
owing to hydropathic changes. As for point mutations, we found
a total of nine variants (4 missense, 3 intronic, and 2 synony-
mous) in five patients (Table S8). Three reported missense vari-
ants were found in exon 1: rs10878075, rs10878074, and
rs10878073. These variants are seemingly in linkage disequilib-
rium and in our cohort three non-deleted patients (CT157,
CT196, 11-387) carried them in heterozygosis and one (CT176)
in homozygosis. The minor allele frequency (MAF) denotes a
high frequency of these variants in the general population; for
instance, the bioinformatic predictions indicate a non-patho-
genic effect of the amino acidic changes. The fourth missense
variant, also described in the databases (rs371693431), was
detected in heterozygosis in exon 4 of one non-deleted patient
only (11-387). This mutation is a serine to leucine substitution
(p.Ser165Leu) in a highly conserved region. No MAF is reported
for this variant and all prediction tools employed in this study
predicted it as potentially pathogenic; for instance, using
TMHMM it is predicted to be located in one of the extramem-
brane loops of the protein and to increase its hydrophobic prop-
erties leading to a consistent change of the protein conformation
(Fig. 2). Of the three intronic variants found in three different
patients, two are reported with a MAF>5% and one is novel, but
all seemingly have no effect on splicing. Interestingly patient
CT175, displaying the lowest value of globozoospermic sperma-
tozoa (50%), had no variants at all.
SPACA1 screening
Sequencing of the whole SPACA1 gene was performed in all
globozoospermic patients. No mutations were found in any of
them.
ART outcome
ART treatment was an option for nine of the patients included
in the study (Table 2). In patients with milder forms of globo-
zoospermia oocyte fertilization occurred, although this was not
always followed by embryo formation. Patients with severe
forms of globozoospermia – who also displayed either the homo-
zygous DPY19L2 deletion or were compound heterozygous –
could not even obtain oocyte fertilization. In the case of patient
CT154 (macrocephalic), although 5 MII oocytes were injected,
none of them was fertilized. Of the other two macrocephalic
patients (11-527 and 12-550), the former did not undergo ART,
whereas the latter underwent an ICSI cycle reaching embryo
transfer, but achieved no pregnancy. We also obtained data on
patient 12-550’s family investigating on his brother’s ART history
(sample 13-039), who displayed a mild form of sperm macro-
cephaly (39%); in this case, 2 ICSI cycles were performed and
both ended in embryo transfer, but both times no pregnancy
was achieved. Pregnancy was achieved only for one couple
(patient 11-387), who went for IVF with a donor’s sample.
DISCUSSION
Sperm macrocephaly and globozoospermia are rare forms of
teratozoospermia causing male infertility. The literatureT
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provides well-defined data concerning sperm macrocephaly, for
which a consensus exists about the genetic etiology and its con-
sequences on sperm genome and ART outcome. Contrastingly,
the picture is rather complex when it comes to globozoospermia,
for which more candidate genes have been proposed and data
on aneuploidy, sperm DF as well as ART outcomes are largely
heterogeneous.
Literature is especially poor of studies where mutational
screening of candidate genes for these two conditions is com-
bined with sperm genomic analysis and ART history. In fact,
such a comprehensive study has been published only for two
patients with sperm macrocephaly (Guthauser et al., 2011; Moli-
nari et al., 2013). Concerning globozoospermia, ours is the first
study providing information about the mutational status of
DPY19L2 and a novel candidate gene (SPACA1) concurrently to
sperm FISH, DF, MSI, and ART outcome.
As expected all patients with macrocephaly had a mutation in
the AURKC gene, directly associated with the pathology. Consis-
tent with the literature, the two North African patients in our
cohort were homozygous for the c.144delC mutation. The two
Spanish brothers, instead, were homozygous for the p.Tyr248*
mutation; as they came from a small town in Spain, their par-
ents’ consanguinity cannot be excluded. Interestingly, patient
12-550’s spermatozoa were all macrocephalic, whereas his
brother displayed a 39% of macrocephalic spermatozoa,
suggesting that the p.Tyr248* mutation has a variable pene-
trance. Unfortunately, sperm morphology data of distinct
p.Tyr248* mutation carriers are not available in the current liter-
ature (Ben Khelifa et al., 2012). In accordance with previous
studies (Benzacken et al., 2001; Devillard et al., 2002; Guthauser
et al., 2006; Perrin et al., 2011; Brahem et al., 2012; Molinari
et al., 2013; Achard et al., n.d.), FISH analysis in spermatozoa
revealed a high rate of tetraploidy in all three tested patients.
Interestingly, the two Moroccan patients carrying the c.1144delC
showed >90% polyploidy, whereas the Spanish patient 12-550
presented a lower value (68.56%) indicating a milder effect of
this mutation on sperm chromosomal constitution. In contrast,
the two patients for whom TUNEL/PI assay was performed
(CT154 and 12-550) displayed a similarly high level of sperm DF
(54.29 and 52%, respectively), regardless of the type of mutation.
As for globozoospermic patients, the genetic analysis included
not only the screening of the DPY19L2 gene, the major genetic
factor causing globozoospermia, but also that of a novel candi-
date gene, SPACA1, here studied for the first time in humans.
The importance of DPY19L2 mutations in the etiology of globo-
zoospermia has been emphasized by Elinati et al. (2012), who
found an involvement of this gene (deletion and/or point muta-
tions on both alleles) in 56% of cases (36/64). We report a fre-
quency of DPY19L2 homozygous deletions of 22.2% (2/9), which
seems to be lower compared with the overall frequency reported
in the literature. Unfortunately, articles available not always pro-
vide data on the consanguinity of homozygous carriers; however,
when considering patients from non-consanguineous families
and those with unknown family history, we estimated that the
frequency of homozygous deletion carriers was of 34.7%.
In our cohort, patients with the severest phenotype had either
a homozygous or a heterozygous DPY19L2 deletion together
with a deletion of exon 7 on the other allele. When it comes to
point mutations, one patient was heterozygous for a deleterious
missense variant, but no other potentially deleterious variants
could be identified. This finding suggests that in men with the
heterozygous mutations the phenotype could either be caused
by a second mutation on another candidate gene (digenic etiol-
ogy) or that the heterozygous mutation is already sufficient to
induce a partial globozoospermia. We propose this later scenario
as the severity of globozoospermia was milder in the heterozy-
gous patient (83%) compared with the two homozygous deletion
carriers (100% globozoospermic) and the compound heterozy-
gote (91%). Moreover, the five patients with wild type DPY19L2
showed the lowest percentage of globozoospermia (50–75%).
Our data therefore confirm that DPY19L2 mutations are impor-
tant contributors to severe forms of globozoospermia suggesting
that its screening should not be restricted to the complete forms.
The diagnosis of both heterozygous and homozygous mutation
is relevant for genetic counseling as loss in DPY19L2 involves 7
over 1000 person in the general population (DGV). The deletion
occurs between two segmental duplications that predispose to
deletion formation during meiosis. Considering that such an
event is not exceptionally rare, screening for the non-allelic
homologous recombination (NAHR)-mediated deletion in the
female partners of male carriers should be advised in order to
predict the possible consequences on the offspring.
The lack of DPY19L2 mutations in the milder forms (50–75%
of globozoospermia) suggests that other genes could be involved
in this phenotype. Concerning other genetic factors previously
Mutant
Wild type
S165L
110
–12
7
193
 21
5(A)
(B)
Figure 2 Bioinformatic analysis of the missense mutation p.Ser165Leu
(rs371693431) in DPY19L2. (A) Prediction of the mutation on the properties
of the involved extramembrane loop of the DPY19L2 protein using the
TMHMM server. Plot of the posterior probabilities for wild type (upper
panel) and mutant (lower panel) sequences of the DPY19L2 proteins are
shown, based on a hidden Markov model approach. The hydrophobicity,
one of the most important parameters incorporated into this model, can be
revealed by the plot. The dashed box highlights the significant increase in
the protein hydrophobic properties caused by the Serine into Leucine
change, which leads to a consistent change in the protein conformation.
(B) Amino acid alignment of partial exon 4 of DPY19L2 selected orthologs,
performed by MultAlin. The box highlights the Serine in position 165.
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proposed to be involved in globozoospermia, data are very
scarce and only single mutation carriers with complete globo-
zoospermia are reported for the SPATA16 and PICK1 gene from
consanguineous families (Dam et al., 2007; Liu et al., 2010).
Later, only SPATA16 was screened in an overall relatively large
group of globozoospermic subjects (n = 65) and no mutation
was found (Dam et al., 2007; Kuentz et al., 2013; Noveski et al.,
2013). Given that research focused on these genes was relatively
unsuccessful, we searched for a not yet tested candidate gene. As
mentioned above, this is the first time that SPACA1 is considered
a candidate gene for human globozoospermia, based on data by
Fujihara et al. (2012), reporting a globozoospermia-like pheno-
type in knockout mice. We found no mutations in SPACA1 in our
globozoospermic patients but, given the small cohort tested, it
cannot be excluded that this gene might still be involved in this
phenotype in humans.
The existence of a clear-cut correlation between globozoosper-
mia and a higher rate of abnormal chromosomal content as well
as higher DF is questioned by the fact that only a proportion of
patients show abnormal values (Machev et al., 2004; Perrin
et al., 2011). In our cohort of globozoospermic patients, we did
found an increase in disomies and diploidies compared with the
reference values; however, inter-individual differences were evi-
dent. For the first time, we tested whether the presence of the
DPY19L2 deletion might confer a higher rate of both sperm an-
euploidies and DF. According to our data, no correlation exists
between the presence of the DPY19L2 deletion and the rate of
abnormal chromosomal content, as patients carrying a DPY19L2
either homozygous (A1869) or heterozygous (CT158) deletion
did not have higher aneuploidy rate compared with non-carrier
globozoospermic patients. Considering sperm DF, also this
parameter was highly variable between patients (32.6–64.9%)
showing on average a significantly higher DF rate (46.9  4.2%)
compared with the 90 controls (34.04  1.5%). In relation to the
presence of the DPY19L2 deletion, both homozygous carriers
displayed a fragmentation rate within the normal range, whereas
DF in the heterozygous carrier was definitely above normality
(61%). Therefore, a clear relationship between the DPY19L2 dele-
tion and a consistently higher DF cannot be established.
ART history was followed for 8/12 patients, of whom none
achieved pregnancy (Table 2). The two patients with 100% large-
headed spermatozoa in the ejaculate showed different
fertilization rate at ICSI: as for the patient carrying the c.144delC
(CT154) and his 28-year-old partner, despite having recovered
5MII oocytes during the ICSI attempt, no oocyte fertilization
occurred; instead, patient 12-550, with the p.Tyr248* mutation
and a 34-year-old partner, managed to fertilize one of two recov-
ered MII oocytes after ICSI, achieving embryo transfer. Embryo
transfer was successful, although not resulting in a pregnancy,
only in patient 12-550’s brother (sample 13-039), who carried
the same mutation but a lower percentage of macrocephalic
spermatozoa.
Concerning the globozoospermic subjects, we observed a cor-
relation between DPY19L2 status and the oocyte fertilization rate;
for instance, for the two patients carrying the DPY19L2 deletion
that underwent ART treatment (A1869 in homozygosis and
CT158 in heterozygosis) oocyte fertilization did not occur, even
when the female partner was young (CT158’s case) or had a per-
fect ovarian response to stimulation (A1869). In non-deleted
patients, instead, the ART procedure was carried out until
embryo transfer, which in no cases, although, developed in a
pregnancy. Given our assumptions above, this correlation is
explained by the DPY19L2-dependent severity of the globozoo-
spermic phenotype, for which the fertilization rate is reduced in
the presence of the genotype leading to a higher percentage of
abnormal spermatozoa that will fail at ICSI. Our data support the
general agreement on a negative correlation existing between
macro/globozoospermia and conventional ICSI outcome (Viville
et al., 2000; Dam et al., 2007; Dirican et al., 2008; Banker et al.,
2009; Kuentz et al., 2013). Unsuccessful fertilization derives from
the missing PLCf-dependent induction of calcium increase in
the oocyte. AOA has been proposed as an option for patients with
complete globozoospermia, although its safety has been ques-
tioned: it is, in fact, advisable to restrict its use to selected cases
and to avoid it when there is a chance of finding normal sperma-
tozoa, as the case of partial globozoospermia (Kuentz et al.,
2013). In these cases, intracytoplasmic morphologically selected
sperm injection (IMSI), have been proposed (Kuentz et al., 2013).
In our cohort, neither AOA nor IMSI have been performed.
Given the very low pregnancy rate observed in these two types
of monomorphic teratozoospermia (Viville et al., 2000; Dam
et al., 2007; Molinari et al., 2013), we aimed to evaluate whether
a higher genomic instability would concur to this phenomena.
Consequently, another novelty of our study is the analysis of
Table 2 History of ART treatment in patients with teratozoospermia
Patient Phenotype No. abortions Partner’s age ART treatment No. recovered oocytes No. fertilized
oocytes
No. embryo
(day 2)
No. embryo
transfer
Pregnancy
CT154 Macro 0 28 IUI NA 0 0 0 No
IVF cycle 0 0 0 0 No
ICSI cycle 5 MII; 1 deg. 0 0 0 No
12-550 Macro 0 34 ICSI cycle 2 MII; 3 prophase 1 1 1 No
13-039a Macro 0 33 1° ICSI cycle 7 MII; 1 deg. 2 2 2 No
2° ICSI cycle NA NA NA NA No
A1869 Globo 0 36 ICSI cycle 11 MII; 1 deg. 0 0 0 No
CT158 Globo 0 29 ICSI cycle 5 MII 0 0 0 No
10-260 Globo 0 35 1° ICSI cycle 3 MII 1 1 1 No
2° ICSI cycle 2 MII; 1 MI 0 0 0 No
3° ICSI cycle 2 MII 1 1 1 No
CT157 Globo 2 39 ICSI cycle 5 MII 2 2 2 No
CT176 Globo 0 38 ICSI cycle 4 MII 3 3 3 No
IUI, intra-uterine insemination; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; MI, maturation phase I; MII, maturation phase II; ART, artificial reproduc-
tive technology; NA, not available. a13-039 is patient 12-550’s brother.
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MSI, which may originate from alteration in the DNA mismatch
repair system and is considered a marker of genomic instability
(Maduro et al., 2003). All patients resulted stable to MSI analysis,
excluding the contribution of genomic instability to the poor
ICSI outcomes.
In summary, this study represents the first comprehensive
clinical characterization of patients suffering infertility because
of two forms of monomorphic teratozoospermia. Our data about
sperm macrocephaly basically confirm previous findings on the
role of AURKC and the exceptionally high aneuploidy rate in this
pathological condition. As for globozoospermia, we observed no
direct relationship between the DPY19L2 status and sperm
anomalies in terms of FISH, DF but a correlation was detected
between the type of DPY19L2 mutations and severity of the phe-
notype and oocyte fertilization. In the light of our data, we agree
that in case of 100% globozoospermia, AOA should be recom-
mended, as there is biological evidence that spermatozoa will
not be able to activate the oocyte alone. DPY19L2 genetic
screening would help to characterize both complete and partial
cases with >80% of globozoospermia, whereas the DPY19L2 sta-
tus of the female partner of mutation carriers will provide addi-
tional information for an appropriate genetic counseling. Apart
from offering a comprehensive spermatozoa and clinical charac-
terization, our study presents a number of novel aspects. We
aimed to provide an alternative technical approach for the
detection of DPY19L2 deletions that might be missed by the pre-
viously proposed DJFA analysis. Therefore, we developed the
qPCR method herein presented for a rapid and highly reliable
analysis of the presence of both common and still undiscovered
DPY19L2 deletions. Importantly, for the first time, we provide
evidence that neither macrocephaly nor globozoospermia are
associated with genomic instability. Finally, the novel candidate
gene herein proposed (SPACA1) and tested for the first time in
human, does not appear a frequent cause of this phenotype in
humans, although studies on a larger study population should
be performed to confirm this conclusion.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of
this article:
Figure S1. Flowchart indicates the molecular investigation performed in
globozoospermic patients and potential outcome.
Figure S2. qPCR amplification plots. (A) Amplification plot of the normal
control carrying two copies of the DPY19L2: no difference is observed
between the Ct values of the DPY19L2 gene and the reference gene
HAL; (B) Amplification plot of the patient carrying the DPY19L2 heterozy-
gous deletion: a difference of one Ct is observed between the DPY19L2
and the reference gene HAL; (C) Amplification plot of the patient carrying
the DPY19L2 homozygous deletion: no amplification is observed for the
DPY19L2.
Table S1. Sequences of primers used for MSI analysis.
Table S2. Sequences of primers used for AURKC analysis.
Table S3. List of primers used for DPY19L2 analysis.
Table S4. List of primers used for SPACA1 analysis.
Table S5. Primers used for qPCR analysis.
Table S6. Frequency of chromosomal anomalies found in patients with
teratozoospermia.
Table S7. AURKCmutations identified in macrocephalic patients.
Table S8. DPY19L2mutations identified in globozoospermic patients.
Data S1. Supplemental Materials and Methods.
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